BD MAX Enteric Viral Panel

FDA 510(k) K220607 · Becton, Dickinson and Company

Substantially Equivalent

510(k) numberK220607

Submission

Device name
BD MAX Enteric Viral Panel
Applicant
Becton, Dickinson and Company
Sparks, MD, US
Received
March 2, 2022
Decision date
September 21, 2022
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PCH – Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3990
Specialty
Microbiology

A gastrointestinal pathogen panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple gastrointestinal microbial nucleic acids extracted from human stool specimens. The detection and identification of a specific gastrointestinal microbial nucleic acid from individuals exhibiting signs and/or symptoms of gastrointestinal…

Other 510(k)s with product code PCH

510(k)DeviceApplicantDecision
K253722LIAISON PLEX Gastrointestinal Flex AssayPCH · Traditional Luminex Corporation05/19/2026SE
K254032QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel…PCH · Traditional QIAGEN GmbH03/09/2026SE
K251721Xpert GI PanelPCH · Traditional Cepheid01/16/2026SE
K252329QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel…PCH · Traditional QIAGEN GmbH10/22/2025SE
K251993Panther Fusion GI Expanded Bacterial AssayPCH · Traditional Hologic, Inc.09/25/2025SE
K251868Panther Fusion GI Bacterial AssayPCH · Traditional Hologic09/25/2025SE
K250324QIAstat-Dx GI Panel 2 Mini BPCH · Special QIAGEN GmbH02/28/2025SE
K243885BIOFIRE FILMARRAY Gastrointestinal (GI) Panel MidPCH · Special Biofire Diagnostics, LLC01/16/2025SE
K242877BioCode Gastrointestinal Pathogen Panel (GPP)PCH · Traditional Applied BioCode, Inc.01/10/2025SE
K243813QIAstat-Dx GI Panel 2 Mini B&VPCH · Special QIAGEN GmbH01/08/2025SE

More from QIAGEN GmbH

510(k)DeviceDecision
K260128BD Preset™ and BD A-Line™ Arterial Blood Collection SyringesJKA · Special 04/15/2026SE
K252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood…JKA · Traditional 04/10/2026SE
K252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood…JKA · Traditional 04/10/2026SE
K260184Onclarity™ Self-Collection KitSEP · Traditional 04/02/2026SE
K252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood…JKA · Traditional 03/13/2026SE
K2508840.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP SyringeNGT · Traditional 12/02/2025SE
K250358BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR…PCI · Traditional 10/31/2025SE
K250059BD PhaSeal™ Optima Connecting Set (C83-O); BD PhaSeal™ Optima Spike Set (C180-O)ONB · Traditional 09/12/2025SE
K251713BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)LON · Traditional 08/08/2025SE
K251350BD Plastipak™ SyringeFMF · Traditional 07/29/2025SE

Questions and answers

When was BD MAX Enteric Viral Panel cleared by the FDA?

BD MAX Enteric Viral Panel (K220607) received a 510(k) decision of Substantially Equivalent on September 21, 2022, 203 days after the submission was received.

What is the product code of K220607?

The FDA product code is PCH – Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System, a Class II (moderate risk) device regulated under 21 CFR 866.3990.